Hamdoun Elwaseila, Karachunski Peter, Nathan Brandon, Fischer Melissa, Torkelson Jane L, Drilling Amy, Petryk Anna
Divisions of Pediatric Endocrinology, and.
Department of Neurology, University of Minnesota, Minneapolis, Minnesota.
Pediatrics. 2016 May;137(5). doi: 10.1542/peds.2015-3418. Epub 2016 Apr 14.
Newborn screening has dramatically reduced rates of untreated congenital hypothyroidism (CH). However, in low-income nations where newborn screening programs do not exist, untreated CH remains a significant health and societal challenge. The goal of this report is to alert health care providers about the potential of undiagnosed CH in unscreened immigrant children. We report 3 siblings of Somali descent with CH who started treatment with levothyroxine at age 0.5 years, 7.7 years, and 14.8 years and were followed for 8 years. This case series demonstrates a spectrum of severity, response to treatment, and neurocognitive and growth outcomes depending on the age at treatment initiation. Patient 1, now 22 years old, went undiagnosed for 14.8 years. On diagnosis, his height was -7.5 SDs with a very delayed bone age of -13.5 SDs. His longstanding CH was associated with empty sella syndrome, static encephalopathy, and severe musculoskeletal deformities. Even after treatment, his height (-5.2 SDs) and cognitive deficits remained the most severe of the 3 siblings. Patient 2, diagnosed at 7.7 years, had moderate CH manifestations and thus a relatively intermediate outcome after treatment. Patient 3, who had the earliest diagnosis at 0.5 years, displayed the best response, but continues to have residual global developmental delay. In conclusion, untreated CH remains an important diagnostic consideration among immigrant children.
新生儿筛查已显著降低了未经治疗的先天性甲状腺功能减退症(CH)的发病率。然而,在没有新生儿筛查项目的低收入国家,未经治疗的CH仍然是一项重大的健康和社会挑战。本报告的目的是提醒医疗保健提供者注意未筛查的移民儿童中未诊断出CH的可能性。我们报告了3名索马里裔患有CH的兄弟姐妹,他们分别在0.5岁、7.7岁和14.8岁开始使用左甲状腺素治疗,并接受了8年的随访。这个病例系列展示了根据治疗开始时的年龄不同,CH的严重程度、对治疗的反应以及神经认知和生长结局的差异。患者1,现年22岁,14.8年未被诊断出病情。诊断时,他的身高低于标准差7.5,骨龄严重延迟,低于标准差13.5。他长期患有的CH与空蝶鞍综合征、静止性脑病和严重的肌肉骨骼畸形有关。即使经过治疗,他的身高(低于标准差5.2)和认知缺陷在3名兄弟姐妹中仍然是最严重的。患者2在7.7岁时被诊断出病情,有中度CH表现,因此治疗后结局相对中等。患者3在0.5岁时最早被诊断出病情,表现出最佳反应,但仍有残留的全面发育迟缓。总之,未经治疗的CH仍然是移民儿童中一个重要的诊断考虑因素。